Medical Evidence Blog

This is discussion forum for physicians, researchers, and other healthcare professionals interested in the epistemology of medical knowledge, the limitations of the evidence, how clinical trials evidence is generated, disseminated, and incorporated into clinical practice, how the evidence should optimally be incorporated into practice, and what the value of the evidence is to science, individual patients, and society.

Showing posts with label generic death; simvastatin; vytorin; Zocor; Merck; Schering-Plough;. Show all posts
Showing posts with label generic death; simvastatin; vytorin; Zocor; Merck; Schering-Plough;. Show all posts
Friday, December 21, 2007

Patients and Physicians should BOYCOTT Zetia and Vytorin: Forcing MRK and SGP to come clean with the data

›
You wouldn't believe it - or would you? The NYT reports today that SGP has data from a number of - go figure - unpublished studies that ...
20 comments:
Sunday, November 25, 2007

Are Merck and Schering-Plough "enhancing" the ENHANCE data?

›
I'm from Missouri, "The Show-Me State," and like many others, I'd like Merck and Schering-Plough to show me the ENHANCE tr...
5 comments:
›
Home
View web version

About Me

My photo
Scott K. Aberegg, M.D., M.P.H.
Professor of Medicine, University of Utah. Former affiliations: Outside Hospital x 7.5 years; Assistant Professor, The Ohio State University; Fellowship & MPH: Johns Hopkins Hospital & Bloomberg School of Public Health, Baltimore, MD; Residency: The University of New Mexico Health Sciences Center; MD: The Ohio State University; BA, Spanish: Miami University, Ohio. All views are my own with NO institutional endorsement.
View my complete profile
Powered by Blogger.